MSB 5.12% $1.39 mesoblast limited

SMH commentary 18 June, page-4

  1. 1,254 Posts.
    lightbulb Created with Sketch. 1404
    Wrong, wrong, wrong @hottuna.

    I have given 2 examples elsewhere on this board whereby MSB could see it in its own interest to allow Teva to exit. Nothing to do with endpoints or statistician's yes/no reports. Just a simple agreement between contracted parties. Nothing complicated.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.